Ro reviews

To start – I want to acknowledge that it’s great to hear that you enjoyed working with passionate teammates (I fully agree this is one of the most special parts of Ro), found the salary process to be equitable, and that our mission in helping patients achieve better health resonated with you. In terms of cons, I want to touch on a few things. Everything we do at Ro is with a patient-centric lens. As a leadership team and at all levels of the company we spend most of our time on this. We won’t always get it right (we may take a bet or make an assumption that doesn’t have the result we thought it would) and we won’t ever reach perfection (there will always be more to do), but it’s truly what we strive for every day. While we certainly do have to engage with our board, it’s always through the lens of how we’re driving value for patients. Decision making at Ro happens across various levels and functions versus with a single small group of people. We are always open to feedback and dialogue from anyone at Ro. In fact, we offer several opportunities - from anonymous AMAs to a weekly jam session with the Founders - for people to raise ideas, questions or concerns. We try as much as possible to give credit and recognition to Ro’ers across the organization when they suggest great ideas or contribute to strong outcomes, so I’m sorry to hear that this was not your experience - that’s not what we’d hope for. One of our company principles is “give feedback/seek feedback” and we have several formal mechanisms to encourage and enable this. While it’s always something we will strive to continuously improve, and some teams and individuals are “better” at it than others, it’s a relatively strong characteristic of Ro’s culture. In that spirit – if you’re willing to speak directly so that I can learn from your experience at Ro, I’d love to talk. Feel free to shoot me a note directly at saman@ro.co. Finally, it’s true that we have had several acquisitions over the last two years – and each of them, in different ways, are part of Ro today. Some are product offerings that have increased our ability to reach and serve patients with a wider variety of needs (the what) and others are part of our technology platform, enabling us to reach patients in new or different ways than we were able to previously (the how). An acquisition can take many forms and it’s very common that acquired companies do not remain stand-alone aspects of the company they join, but that does not mean that they aren’t continuing to drive innovation and value to patients. Saman Co-Founder and Chief Product Officer